These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 22021038)
21. The Role of ALDH in the Metastatic Potential of Osteosarcoma Cells and Potential ALDH Targets. Belayneh R; Weiss K Adv Exp Med Biol; 2020; 1258():157-166. PubMed ID: 32767240 [TBL] [Abstract][Full Text] [Related]
22. Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay. Moreb JS; Zucali JR; Ostmark B; Benson NA Cytometry B Clin Cytom; 2007 Jul; 72(4):281-9. PubMed ID: 17111384 [TBL] [Abstract][Full Text] [Related]
23. Interaction of human aldehyde dehydrogenase with aromatic substrates and ligands. Allali-Hassani A; Weiner H Chem Biol Interact; 2001 Jan; 130-132(1-3):125-33. PubMed ID: 11306037 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity. Muramoto GG; Russell JL; Safi R; Salter AB; Himburg HA; Daher P; Meadows SK; Doan P; Storms RW; Chao NJ; McDonnell DP; Chute JP Stem Cells; 2010 Mar; 28(3):523-34. PubMed ID: 20054864 [TBL] [Abstract][Full Text] [Related]
25. Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase. Rekha GK; Sreerama L; Sladek NE Biochem Pharmacol; 1994 Nov; 48(10):1943-52. PubMed ID: 7986206 [TBL] [Abstract][Full Text] [Related]
26. Identification of 4-(N,N-dipropylamino)benzaldehyde as a potent, reversible inhibitor of mouse and human class I aldehyde dehydrogenase. Russo J; Chung S; Contreras K; Lian B; Lorenz J; Stevens D; Trousdell W Biochem Pharmacol; 1995 Jul; 50(3):399-406. PubMed ID: 7646541 [TBL] [Abstract][Full Text] [Related]
28. ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells. Moreb JS; Baker HV; Chang LJ; Amaya M; Lopez MC; Ostmark B; Chou W Mol Cancer; 2008 Nov; 7():87. PubMed ID: 19025616 [TBL] [Abstract][Full Text] [Related]
29. Structural and biochemical characterization of a novel aldehyde dehydrogenase encoded by the benzoate oxidation pathway in Burkholderia xenovorans LB400. Bains J; Boulanger MJ J Mol Biol; 2008 Jun; 379(3):597-608. PubMed ID: 18462753 [TBL] [Abstract][Full Text] [Related]
30. Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors. Morgan CA; Hurley TD J Med Chem; 2015 Feb; 58(4):1964-75. PubMed ID: 25634381 [TBL] [Abstract][Full Text] [Related]
31. Diethylaminobenzaldehyde is a covalent, irreversible inactivator of ALDH7A1. Luo M; Gates KS; Henzl MT; Tanner JJ ACS Chem Biol; 2015 Mar; 10(3):693-7. PubMed ID: 25554827 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of cytosolic class 3 aldehyde dehydrogenase by antisense oligonucleotides in rat hepatoma cells. Muzio G; Canuto RA; Trombetta A; Maggiora M Chem Biol Interact; 2001 Jan; 130-132(1-3):219-25. PubMed ID: 11306046 [TBL] [Abstract][Full Text] [Related]
33. Structures of Proline Utilization A (PutA) Reveal the Fold and Functions of the Aldehyde Dehydrogenase Superfamily Domain of Unknown Function. Luo M; Gamage TT; Arentson BW; Schlasner KN; Becker DF; Tanner JJ J Biol Chem; 2016 Nov; 291(46):24065-24075. PubMed ID: 27679491 [TBL] [Abstract][Full Text] [Related]
34. Mitochondrial aldehyde dehydrogenase, a potential drug target for protection of heart and brain from ischemia/reperfusion injury. Luo XJ; Liu B; Ma QL; Peng J Curr Drug Targets; 2014; 15(10):948-55. PubMed ID: 25163552 [TBL] [Abstract][Full Text] [Related]
35. De novo expression of transfected human class 1 aldehyde dehydrogenase (ALDH) causes resistance to oxazaphosphorine anti-cancer alkylating agents in hamster V79 cell lines. Elevated class 1 ALDH activity is closely correlated with reduction in DNA interstrand cross-linking and lethality. Bunting KD; Townsend AJ J Biol Chem; 1996 May; 271(20):11884-90. PubMed ID: 8662658 [TBL] [Abstract][Full Text] [Related]
36. A patent review on aldehyde dehydrogenase inhibitors: an overview of small molecule inhibitors from the last decade. Kundu B; Iyer MR Expert Opin Ther Pat; 2023 Oct; 33(10):651-668. PubMed ID: 38037334 [TBL] [Abstract][Full Text] [Related]
37. Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase. Bunting KD; Lindahl R; Townsend AJ J Biol Chem; 1994 Sep; 269(37):23197-203. PubMed ID: 8083225 [TBL] [Abstract][Full Text] [Related]
38. Differences in nucleotide specificity and catalytic mechanism between Vibrio harveyi aldehyde dehydrogenase and other members of the aldehyde dehydrogenase superfamily. Zhang L; Ahvazi B; Szittner R; Vrielink A; Meighen E Chem Biol Interact; 2001 Jan; 130-132(1-3):29-38. PubMed ID: 11306028 [TBL] [Abstract][Full Text] [Related]
39. Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide. Moreb J; Schweder M; Suresh A; Zucali JR Cancer Gene Ther; 1996; 3(1):24-30. PubMed ID: 8785707 [TBL] [Abstract][Full Text] [Related]
40. Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis. Ahmed Laskar A; Younus H Drug Metab Rev; 2019 Feb; 51(1):42-64. PubMed ID: 30514131 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]